文献速递妇科肿瘤支持与姑息治疗

WRITE症状干预对复发性卵巢癌患者症状与生活质量的影响:NRG肿瘤学/GOG研究(GOG-0259)

Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
PubMed 文献 · J Clin Oncol · 2022-02-07

GOG-259为三臂随机对照试验,比较护士引导(Nurse-WRITE)与自我管理(SD-WRITE)两种网络症状管理干预对比强化常规照护(EUC)在复发性卵巢癌患者中的疗效。共497例患者入组,主要终点为症状负担、可控性及生活质量。结果显示三组症状负担与生活质量随时间均显著改善(P<.001),WRITE两干预组在症状可控性上较EUC有显著更大改善,Nurse-WRITE与SD-WRITE间无显著差异。

要点

  • 在复发性卵巢癌患者中,Nurse-WRITE与SD-WRITE两干预组从基线至8周和12周的症状可控性改善均显著优于EUC。
  • Nurse-WRITE与SD-WRITE之间在症状可控性改善上无显著差异。
  • 三组症状负担与生活质量随时间均显著改善(P<.001),组间交互作用仅见于症状可控性(P<.001)。

核心结论

  • WRITE两干预组在症状可控性上从基线至8周和12周较EUC有显著更大改善,Nurse-WRITE与SD-WRITE间无显著差异。
  • SD-WRITE具有作为未来实施研究的可扩展干预的潜力。

研究设计与样本

  • GOG-259为三臂随机对照试验,纳入复发性或持续性卵巢癌、输卵管癌或原发性腹膜癌且伴有3个及以上症状的患者。
  • 参与者共497例,平均年龄59.3±9.2岁,随机分组前完成基线的症状负担、可控性及生活质量调查。
  • WRITE干预持续8周,针对三个目标症状制定症状管理计划;所有女性均接受EUC(每月在线症状评估并提供供者报告、在线资源及每2周电子邮件)。
  • 结局在基线后8周和12周评估,采用重复测量模型与线性对比分析组别与时间对症状负担、可控性及生活质量的效应,并控制关键协变量。

主要发现

  • 基线时84%正在接受化疗,平均报告14.2±4.9个并发症状,最常见为疲乏、便秘和周围神经病变。
  • 三组症状负担与生活质量随时间均显著改善(P<.001)。
  • 症状可控性存在组别与时间交互作用(P<.001):WRITE两干预组从基线至8周和12周均有相似改善,而EUC未随时间改善。
  • WRITE两干预组从基线至8周和12周的症状可控性改善均显著大于EUC。
  • Nurse-WRITE与SD-WRITE之间无显著差异。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL). METHODS: Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ symptoms were eligible for the study. Participants completed baseline (BL) surveys (symptom burden and controllability and QOL) before random assignment. WRITE interventions lasted 8 weeks to develop symptom management plans for three target symptoms. All women received EUC: monthly online symptom assessment with provider reports; online resources; and every 2-week e-mails. Outcomes were evaluated at 8 and 12 weeks after BL. Repeated-measures modeling with linear contrasts evaluated group by time effects on symptom burden, controllability, and QOL, controlling for key covariates. RESULTS: Participants (N = 497) reported mean age of 59.3 ± 9.2 years. At BL, 84% were receiving chemotherapy and reported a mean of 14.2 ± 4.9 concurrent symptoms, most commonly fatigue, constipation, and peripheral neuropathy. Symptom burden and QOL improved significantly over time (P < .001) for all three groups. A group by time interaction (P < .001) for symptom controllability was noted whereby both WRITE intervention groups had similar improvements from BL to 8 and 12 weeks, whereas EUC did not improve over time. CONCLUSION: Both WRITE Intervention groups showed significantly greater improvements in symptom controllability from BL to 8 and BL to 12 weeks compared with EUC. There were no significant differences between Nurse-WRITE and SD-WRITE. SD-WRITE has potential as a scalable intervention for a future implementation study.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Donovan HS, Sereika SM, Wenzel LB, et al. Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259). J Clin Oncol. 2022. PMID: 35130043. doi:10.1200/JCO.21.00656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。